Weill Cornell Medicine is collaborating with colleagues in Tanzania to increase the pipeline of female doctors, researchers and policymakers in health care, and focus attention on women’s health in Tanzania.
Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new study from researchers at Weill Cornell Medicine.
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial.
The study found heart failure rates were higher in flooded areas, especially in New Jersey, and that the risk persisted for four to five years – not just weeks or months – after the storm.
Surrounded by friends and family, 106 students in the Class of 2029 participated in Weill Cornell Medical College’s annual White Coat Ceremony on Aug. 12, officially marking the beginning of their medical education.
COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young children lacking immunity to pathogens they otherwise would have been exposed to, a new study reveals.
By understanding differences in how people’s brains are wired, clinicians may be able to predict who’d benefit from a self-guided anxiety care app, according to a clinical trial co-led by Weill Cornell Medicine investigators.
Dr. Jennifer Downs of Weill Cornell Medicine is collaborating with Tanzanian researchers to treat schistosomiasis, a parasitic worm infection affecting 250 million people worldwide.
